-
257 drug price adjustments, 277 into the price linkage catalog!
Time of Update: 2022-06-09
Include 277 national emergency rescue medicines, pediatric generic medicines demonstration catalogue medicines, and shortage medicines into the 2022 inter-provincial price linkage catalogue From the perspective of the industry, Hunan Province has launched a drug price limit listing, which is intended to solve the inflated drug prices and rectify the order of the pharmaceutical market .
-
Express AI helps develop innovative protein degraders, and Boehringer Ingelheim reaches R&D cooperation
Time of Update: 2022-06-09
References:References: [1] VantAI Forms Research Collaboration with Boehringer Ingelheim to Identify Novel Protein Degraders.
html[1] VantAI Forms Research Collaboration with Boehringer Ingelheim to Identify Novel Protein Degraders.
Retrieved April 21, 2022, from https:// -Forms-Research-Collaboration-with-Boehringer-Ingelheim-to-Identify-Novel-Protein-Degraders.
Retrieved April 21, 2022, from https:// -Forms-Research-Collaboration-with-Boehringer-Ingelheim-to-Identify-Novel-Protein-Degraders.
-
Biogen completes sale of Samsung Bioepis stake for $2.3 billion
Time of Update: 2022-06-09
In addition, Biogen holds the exclusive commercialization rights to ranibizumab and biosimilars under investigation of aflibercept .
In just 10 years, Samsung Bioepis has approved 6 biosimilars (ranibizumab, bevacizumab, trastuzumab, adalimumab, infliximab and etanercept) .
-
"Dual-channel" special drug retail performance revealed
Time of Update: 2022-06-09
Table 5: Unit price (RMB) changes of 19 specialty drugs in sample pharmacies in Q1 and Q2021 Note: No sample pharmacy sales data were monitored for tetrabenazine (Teva), edaravone (CP Fenghai), and clopasvir (Kaininger) in the first half of 2021 2.
-
Regeneron VS Gilead: Two modes, the same goal
Time of Update: 2022-06-09
For example, after Regeneron Pharmaceuticals launched the ophthalmic drug Eylea in 2011, it gained a 22% market share in the field of macular degeneration treatment in the United States in the first year, which opened the way for the stock price to soar; after Gilead launched the HIV drug Truvada, the company also started Recognized by the capital market .
-
ASCO Annual Meeting Preview!
Time of Update: 2022-06-09
Rongchang Bio: VidicitumumabRongchang Bio: Vidicitumumab Mechanism of Action: Anti-HER2 Antibody ConjugatesMechanism of Action: Anti-HER2 Antibody Conjugates Indications: urothelial carcinoma, HER2-expressing solid tumorsIndications: urothelial carcinoma, HER2-expressing solid tumors According to Rongchang Bio’s press release, three latest clinical studies of the company’s self-developed anti-HER2 antibody-drug conjugate (ADC) Vidicitumab were selected for the 2022 ASCO Annual Meeting, and will constitute Vidicitumab at the same time.
-
Long-lasting wrinkle removal!
Time of Update: 2022-06-09
Retrieved Dec 5, 2018, from https:// [3] Revance Announces Publication of Results on Static Glabellar Lines With Repeated Treatment of DaxibotulinumtoxinA for Injection From the SAKURA Clinical Program in Dermatologic Surgery .
-
67 major varieties of patents expire, who will be the first to imitate?
Time of Update: 2022-06-09
Table 2: (Partial) Potential Therapeutic Area/Generic Name Patent Expired Drugs Market size forecast in 2025 Source: New Drug Development Monitoring Database (CPM), China Pharmaceutical Industry Information Center 03.
-
There are new regulations on the amount of centralized procurement, and the non-selected varieties have a new chance
Time of Update: 2022-06-09
Too few reports, resulting in the actual use of medical institutions exceeding 200% or even 400% of the predicted purchases At the end of June 2021, the Yunnan Provincial Drug Collection Platform showed that acarbose, amoxicillin granules, metformin hydrochloride sustained-release tablets and other varieties increased the declaration work of national drug supplement supply enterprises .
-
Stop squeezing!
Time of Update: 2022-06-09
According to a recent report by Reuters, Pfizer plans to produce up to 120 million courses of Paxlovid this year, with contracted sales expected to be at least $22 billion as of early February .
-
Biotech will cut meat to survive without money?
Time of Update: 2022-06-09
Once the market value of Biotech drops sharply, not only the stocks pledged and financed by the founding management team will face the risk of liquidation, delisting is not impossible, and it is more commonly possible that there will be a knock on the door from the barbarians .
-
Prokalutamide on a roller coaster, Zirissovir in a marathon Industry Observation
Time of Update: 2022-06-09
Another product, chiresovir, was mentioned in the press release published by ARK Baifa, which is the first RSV antiviral drug in the world to successfully complete a pivotal Phase III study in a pediatric patient population .
-
How to choose a residual chlorine online monitor?
Time of Update: 2022-06-08
The residual chlorine online monitor is widely used in circulating water automatic control dosing, swimming pool chlorination control and continuous monitoring and control of residual chlorine content in aqueous solutions in drinking water treatment plants, drinking water distribution networks, swimming pools, hospital wastewater, water quality treatment projects, etc.
The free chlorine remaining after killing bacteria is residual chlorine .
-
Types and working principles of residual chlorine online analyzers
Time of Update: 2022-06-08
Some people found that raw water contains a lot of parasites and bacteria, so people use chlorine gas for disinfection, but too high chlorine content will also cause harm to the human body, and finally there is a residual chlorine online analyzer .
-
How much do you know about low adsorption centrifuge tubes?
Time of Update: 2022-06-07
Low adsorption centrifuge tubes are often used for protein concentration and desalting operations, buffer exchange or desalting operations for chromatographic washes and physiological gradient fragments, and recovery of biomolecules from bacterial culture supernatants or lysates of cells .
-
Wrong matters in the application of automatic welding machine for stainless steel pipes
Time of Update: 2022-06-07
Basically, it involves making food grade welding and metal for equipment used throughout the consumables industry .
For some customers who do not dare to try boldly at the beginning, we can also provide you with on-site pipeline installation and construction services of stainless steel pipeline automatic welding machine .
-
Regeneron acquires Checkmate for $250M, collaborates with SpringWorks on multiple myeloma therapy
Time of Update: 2022-06-07
A few days ago, Regeneron announced the acquisition of Checkmate Pharmaceuticals, and also said that it will cooperate with SpringWorks Therapeutics on a clinical trial to jointly evaluate the efficacy of Regeneron REGN5458 in combination with SpringWorks drug nirogacestat in patients with multiple myeloma .
-
Bluebird New Hope?
Time of Update: 2022-06-07
Pharmaphorum stated in the report that beti-cel has been approved for marketing in the European Union and the United Kingdom, and the drug’s debut price in the United Kingdom is about 1.
-
Raised over $500 million in two years!
Time of Update: 2022-06-07
Recently, Tessera Therapeutics, a biotechnology company dedicated to pioneering new technologies in gene therapy, announced that it has received more than $300 million in Series C financing .
From https:// Tessera Therapeutics Announces Over $300M Series C Financing to Advance its GENE WRITING Platform.
-
One-arm trial + ORR may not be enough?
Time of Update: 2022-06-07
On April 14, Nicholas, an officer of the FDA Oncology Center of Excellence (OCE), and others published an article in The Lancet-Oncology: The development program of PI3K inhibitors in hematological malignancies highlights the challenges associated with the current paradigm of using overall response rate (ORR) in single-arm trials to support accelerated approval .
